FDA Law Blog
JANUARY 1, 2024
Four of the letters addressed failure to comply with drug Current Good Manufacturing Practice regulations, four more stated that the recipients were distributing unapproved drug products, two alleged violations of the Quality System Regulation by medical device manufacturers, and one was addressed to a clinical investigator.
Cloudbyz
AUGUST 19, 2024
This process includes the following key stages: Risk Assessment: Identifying potential risks associated with the device’s design, production, and use. Incident Response: Establishing a plan for responding to cybersecurity incidents, including detection, containment, eradication, and recovery.
FDA Law Blog
JUNE 9, 2021
Koblitz — While typically, FDA is responsible for setting forth its own agenda and enforcing compliance with its own regulations, the Trump Administration’s HHS, on its way out the door in late 2020 , took the unusual steps of withdrawing an important FDA Compliance Policy Guide, “Marketed Unapproved Drugs – Compliance Policy Guide Sec.
Expert insights. Personalized for you.
59 
Let's personalize your content